Research Article

Development of Live Vaccine Candidates for Canine Influenza H3N2 Using Naturally Truncated NS1 Gene

Figure 9

Protection efficacy of mice vaccinated with commercial vaccine or CIVSA1. The vaccinated or PBS-inoculated mice were challenged with CIV at a dose of 106.5 EID50. The mice lungs and nasal washes were collected on dpc 2 (n = 5) and 4 (n = 5). TCID50 assay was performed for four types of samples: (a) dpc2 lungs, (b) dpc4 lungs, (c) dpc2 nasal washes, and (d) dpc4 nasal washes. The results were expressed as mean ± SD. Statistical significance was calculated using a one-way analysis of variance (one-way ANOVA) (, ,).
(a)
(b)
(c)
(d)